Volume 87, Issue 6, 2022-12-1, Pages A9-e255

Articles in this issue:

1. Editorial Board

2. Table of Contents

3. Information for Readers

4. JAAD Case Reports Article List

5. Journal Based CME Instructions and Information

6. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color – Part I: Genetic, biologic, and structural differences in skin of color

7. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color

8. Letter from the Editor: Management of cutaneous polyarteritis nodosa

9. Diversity, equity, and inclusion: The visionary future of JAAD

10. Understanding health outcomes and health equity

11. The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections

12. This Month in JAAD: December 2022

13. This Month in JAAD Case Reports: December 2022. Hidradenitis suppurative and malignancy

14. This Month in JAAD International: December 2022: Topical management of vitiligo with Janus kinase inhibitors

15. Immune checkpoint inhibitor-induced bullous pemphigoid quandaries

16. Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis

17. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease

18. Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry

19. Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

20. Exposure to air pollution and incidence of atopic dermatitis in the general population: A national population-based retrospective cohort study

21. Long-pulsed neodymium-doped yttrium-aluminum-garnet laser versus cryotherapy for the treatment of cutaneous warts: A randomized controlled trial

22. Artificial intelligence in the detection of skin cancer

23. Deep learning for dermatologists: Part I. Fundamental concepts

24. Deep learning for dermatologists: Part II. Current applications

25. The history of lupus throughout the ages

26. Cutaneous polyarteritis nodosa diagnosis and treatment: A retrospective case series

27. Disease flare in patients with dermatomyositis following COVID-19 vaccination

28. Baricitinib for the treatment of cutaneous dermatomyositis: A prospective, open-label study

29. Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery: Rates of positive margins, local recurrence, and repeat surgeries

30. Alcohol use disorder among adults with atopic dermatitis: A case-control study in the All of Us research program

31. Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial

32. Sunscreen-using U.S. adults are using higher sun protection factor sunscreens: Data from the National Health Interview Survey 2005-2015

33. Disparities in psoriasis clinical trials: A cross-sectional analysis

34. Prospective study evaluating the personal history of rosacea and risk of cutaneous squamous cell carcinoma among women in the United States

35. Cutaneous manifestations of monogenic auto-inflammatory diseases: An international cohort study from the Juvenile Inflammatory Rheumatism cohort

36. A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes

37. The risk of COVID-19 in patients with psoriasis: A retrospective cohort study

38. Value of permanent pathology for debulk and Mohs specimens during Mohs micrographic surgery for cutaneous squamous cell carcinoma: A retrospective cohort study

39. Impact of isotretinoin on inflammatory bowel disease flare in patients with preexisting inflammatory bowel disease diagnosis: A cross-sectional study

40. Bullous pemphigoid after anti–programmed death-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes

41. Bidirectional association between hyperhidrosis and depressive disorders: A population-based cohort study

42. Utilization of sentinel lymph node biopsy for Merkel cell carcinoma

43. Practice patterns of dermatologists who have opted out of Medicare

44. Citation indicators revisited: Reply to Top Authors in Dermatology

45. Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study

46. Sociodemographic disparities in patch testing for commercially insured patients with dermatitis: A retrospective analysis of administrative claims data

47. Racial and ethnic differences in hospital admissions for cellulitis in the United States: A cross-sectional analysis

48. A cross-sectional analysis of the environmental and cost-saving benefits of digital dermatologic care

49. Type 2 diabetes mellitus and central centrifugal cicatricial alopecia severity

50. Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series

51. Regional disparities in the dermatology workforce: A longitudinal analysis of American Medical Association workforce data

52. Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs surgery

53. Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter study

54. From the Cochrane library: Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings

55. Methotrexate for oral mucous membrane (cicatricial) pemphigoid: experience at an academic dermatology outpatient clinic

56. Skin of color representation in dermatology atlases

57. Dermatoscopic features differentiating among port wine stain, arteriovenous malformation, and capillary malformation-arteriovenous malformation syndrome: to detect potential fast-flow vascular malformations at an early stage

58. Reply to “Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study”

59. Type 1 and type 2 psoriasis revisited: No association between age at onset and disease course

60. Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study

61. Dermatologic visits in the emergency department before and after the Affordable Care Act

62. Clearance of multiple cutaneous warts by targeting a single lesion: A randomized comparative evaluation of mild local hyperthermia versus cryotherapy

63. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy

64. Validation of the Index for Facial Angiofibromas: A new scoring tool to assess facial angiofibromas in the tuberous sclerosis complex

65. Clinical course, diagnostic patterns, and treatment outcomes in patients with pityriasis rubra pilaris

66. Association of autoimmune comorbidities with lichen planus: A United States-based case-control study in the All of Us research program

67. Engagement in sun-protective practices based on health insurance coverage: A cross-sectional analysis

68. The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis

69. The paradoxical promotion of ultraviolet tanning by US tanning salons offering a sunless option: A cross-sectional secret shopper study

70. Dermatologists, not “providers”

71. The Resident Physician Shortage Reduction Act: An opportunity to address the rural dermatology workforce deficit

72. Ethics of discounted cosmetic procedures for permission to post patient photos on social media

73. The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe

74. Pediatric Game Changers∗: Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis

75. An approach to suture needle reloading to reduce the risk of sharps injury and needle contamination

76. Vessel loop tourniquet for penis dermatologic surgery

77. An innovative technique for the separation of toes to prevent and treat intertrigo of toe web space

78. Two methods using topographic landmarks to identify and preserve the spinal accessory nerve during dermatologic surgery

79. Electrosurgical epilation using acupuncture needles for unwanted white hairs after surgery

80. Novel application of cardboard for using wound dressings

81. Reply to “Local recurrence of clinically observed basal cell carcinoma…”

82. Reply to “Response to Collins et al.’s ‘Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia’”

83. Response to the study by Collins et al “Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia.”

84. Top authors in dermatology

85. Comment on “Current outbreak of monkeypox: Essentials for the dermatologist”

86. Reply to “Comment on ‘Current outbreak of monkeypox: essentials for the dermatologist’”

87. Reply to Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia

88. Response to Weinstein’s “ Reply of Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia.”

89. Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil

90. Reply to “Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study”

91. Comment on “Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab”

92. First, do no harm: The urgent need for comprehensive clinical guidelines for diagnostic testing of recalcitrant “atopic dermatitis”

93. Reply to: “Comment on ‘Bullous pemphigoid after anti–PD-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes’”

94. Comment on “Bullous pemphigoid after anti–PD-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes”

95. Reviewers’ List December 2022